Stonepine Capital Management »

Satellos Bioscience shares owned by Stonepine Capital Management

Quarter-by-quarter ownership of Satellos Bioscience (MSLE) shares owned by Stonepine Capital Management from 13F filings

Historical chart of Stonepine Capital Management investment in Satellos Bioscience

Tip: Access up to 7 years of quarterly data

All positions including Satellos Bioscience held by Stonepine Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Satellos Bioscience by Stonepine Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $563k 100k 5.63

More positions owned by Stonepine Capital Management

Spdr Series Trust State Street Spd Put Option (XBI)
Verastem Com New (VSTM)
Adma Biologics (ADMA)
Tenax Therapeutics Com New (TENX)
Evolus (EOLS)
Camp4 Therapeutics Corp (CAMP)
Nektar Therapeutics Com New (NKTR)
Terns Pharmaceuticals Call Option (TERN)
Zevra Therapeutics Com New (ZVRA)
Abeona Therapeutics Com New (ABEO)
Corbus Pharmaceuticals Hldgs Com New (CRBP)
Establishment Labs Holdings Ord Call Option (ESTA)
Kazia Therapeutics Sponsored Ads (KZIA)
An2 Therapeutics (ANTX)
Alexandria Real Estate Equities Call Option (ARE)

View all positions for Stonepine Capital Management

Top funds holding Satellos Bioscience

Franklin Resources
Siren
Vivo Capital
Point72 Asset Management
Woodline Partners
Sphera Funds Management
Suvretta Capital Management
Soleus Capital Management
Avidity Partners Management
Adage Capital Partners GP
Saturn V Capital Management
Millennium Management
683 Capital Management
Empery Asset Management
ADAR1 Capital Management

View all funds holding Satellos Bioscience